S Motoya, K Watanabe, H Ogata,
T Kanai, T Matsui… - PLoS …, 2019 - journals.plos.org
Background Vedolizumab safety and efficacy have been established in many populations all
over the world, but have never been studied in Japan. We report results from a Phase 3 …